Home > Balance Sheet > GLAND PHARMA

GLAND PHARMA
Capital Work in Progress

    Back to Balance Sheet
GLAND PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Capital Work in Progress ₹151 Cr₹238 Cr₹177 Cr₹181 Cr₹338 Cr

What is the latest Capital Work in Progress ratio of GLAND PHARMA ?

The latest Capital Work in Progress ratio of GLAND PHARMA is ₹151 Cr based on Mar2025 Consolidated results.
Year Capital Work in Progress
Mar2025₹151 Cr
Mar2024₹238 Cr
Mar2023₹177 Cr
Mar2022₹181 Cr
Mar2021₹338 Cr

How is Capital Work in Progress of GLAND PHARMA Trending?

Years Capital Work in Progress % Change
Mar2025 ₹151 Cr
-36.71
Mar2024 ₹238 Cr
34.23
Mar2023 ₹177 Cr
-1.95
Mar2022 ₹181 Cr
-46.49
Mar2021 ₹338 Cr -

Compare Capital Work in Progress of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹27,682.3 Cr -1.4% -8.1% -4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,513.0 Cr -0.1% 3.4% -0.1% Stock Analytics
DIVIS LABORATORIES ₹170,614.0 Cr 1.6% -2.5% 8.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹128,245.0 Cr 0.8% -0.9% 13.5% Stock Analytics
CIPLA ₹122,555.0 Cr 1.3% -0.6% 3.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,803.0 Cr 1% 3.7% 2.7% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-1.4%

-8.1%

-4%

SENSEX

-0.5%

1%

4.6%


You may also like the below Video Courses